Genotyping of peroxisome proliferator-activated receptor gamma (PPAR-γ) polymorphism (pro12ala) in Iranian population

Journal of Research in Medical Sciences

Volumn 16, Issue 3, 2011, Pages 291-296

  Namvaran, Fatemeh ^a,b   Rahimi Moghaddam, Parvaneh ^a   Azarpira, Negar ^b  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Genetic; Iran; Polymorphism; Ppar gamma

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ALLELE; ARTICLE; CONTROLLED STUDY; GENE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HUMAN; IRAN; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOPOROSIS; POPULATION DISTRIBUTION; PPAR GENE; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 79955490256     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Michalik L, Auwerx J, Berger JP, Chatterjee VK, Glass CK, Gonzalez FJ, et al. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors. Pharmacol Rev 2006; 58(6): 726-41.
2. Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 1999; 20(5): 649-88.
3. Olefsky JM. Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists. J Clin Invest 2000; 106(4): 467-72.
4. Saltiel AR, Olefsky JM. Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes 1996; 45(12): 1661-9.
5. Berger J, Moller DE. The mechanisms of action of PPARs. Annu Rev Med 2002; 53: 409-35.
6. Chen G, Lin X, Liang J, Lin L. Relationship between polymorphism of PPAR gamma gene and osteoporosis in aged male. Bone 2008; 43: S122.
7. Yue H, He JW, Zhang H, Hu WW, Hu YQ, Li M, et al. No association between polymorphisms of peroxisome [corrected] proliferator-activated receptor-gamma gene and peak bone mineral density variation in Chinese nuclear families. Osteoporos Int 2010; 21(5): 873-82.
8. Yen CJ, Beamer BA, Negri C, Silver K, Brown KA, Yarnall DP, et al. Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation. Biochem Biophys Res Commun 1997; 241(2): 270-4.
9. Michalik L, Desvergne B, Wahli W. Peroxisome-proliferator-activated receptors and cancers: complex stories. Nat Rev Cancer 2004; 4(1): 61-70.
10. Prasad KN, Saxena A, Ghoshal UC, Bhagat MR, Krishnani N. Analysis of Pro12Ala PPAR gamma polymorphism and Helicobacter pylori infection in gastric adenocarcinoma and peptic ulcer diseas. Ann Oncol 2008; 19(7): 1299-303.
11. Schmidt A, Endo N, Rutledge SJ, Vogel R, Shinar D, Rodan GA. Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids. Mol Endocrinol 1992; 6(10): 1634-41.
12. Deeb SS, Fajas L, Nemoto M, Pihlajamäki J, Mykkänen L, Kuusisto J, et al. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 1998; 20(3): 284-7.
13. Paltoo D, Woodson K, Taylor P, Albanes D, Virtamo J, Tangrea J. Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) gene and risk of prostate cancer among men in a large cancer prevention study. Cancer Lett 2003; 191(1): 67-74.
14. Paynter RA, Hankinson SE, Colditz GA, Hunter DJ, De Vivo I. No evidence of a role for PPARgamma Pro12Ala polymorphism in endometrial cancer susceptibility. Pharmacogenetics 2004; 14(12): 851-6.
15. Gong Z, Xie D, Deng Z, Bostick RM, Muga SJ, Hurley TG, et al. The PPAR{gamma} Pro12Ala polymorphism and risk for incident sporadic colorectal adenomas. Carcinogenesis 2005; 26(3): 579-585.
16. Liao SY, Zeng ZR, Leung WK, Zhou SZ, Chen B, Sung JJ, et al. Peroxisome proliferator-activated receptorgamma Pro12Ala polymorphism, Helicobacter pylori infection and non-cardia gastric carcinoma in Chinese. Aliment Pharmacol Ther 2006; 23(2): 289-94.
17. Tahara T, Arisawa T, Shibata T, Nakamura M, Wang F, Maruyama N, et al. Influence of peroxisome proliferatoractivated receptor (PPAR)gamma Plo12Ala polymorphism as a shared risk marker for both gastric cancer and impaired fasting glucose (IFG) in Japanese. Dig Dis Sci 2007; 53(3): 614-21.
18. Paracchini V, Pedotti P, Taioli E. Genetics of leptin and obesity: a HuGE review. Am J Epidermiol 2005; 162(2): 101-14.
19. Gouda HN, Sagoo GS, Harding AH, Yates J, Sandhu MS, Higgins JP. The association between the peroxisome proliferator-activated receptor gamma2 (PPARG2) Pro12Ala gene variant and type 2 diabetes mellitus: a HuGE review and meta-analysis. Am J Epidemiol 2010; 171(6): 645-55.
20. Vigouroux C, Fajas L, Khallouf E, Meier M, Gyapay G, Lascols O, et al. Human peroxisome proliferators activated receptor-gamma2: genetic mapping, identification of a variant in the coding sequence, and exclusion as the gene responsible for lipoatrophic diabetes. Diabetes 1998; 47(3): 490-2.
21. Mori H, Ikegami H, Kawaguchi Y, Seino S, Yokoi N, Takeda J, et al. The Pro12 -->Ala substitution in PPARgamma is associated with resistance to development of diabetes in the general population: possible involvement in impairment of insulin secretion in individuals with type 2 diabetes. Diabetes 2001; 50(4): 891-4.
22. Doney A, Fischer B, Frew D, Cumming A, Flavell DM, World M,et al. Haplotype analysis of the PPARγ Pro12Ala and C1431T variants reveals opposing associations with body weight. BMC Genet 2002; 3: 21.
23. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem 1995; 270(22): 12953-6.
24. Deeb SS, Fajas L, Nemoto M, Pihlajamäki J, Mykkänen L, Kuusisto J, et al. A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index, and improved insulin sensitivity. Nat Genet 1998; 20(3): 284-7.
25. Rs1801282. [cited 2011 March 6]. Available from URL: http://www.snpedia.com/index.php/Rs1801282
26. Kao WH, Coresh J, Shuldiner AR, Boerwinkle E, Bray MS, Brancati FL, et al. Pro12Ala of the peroxisome proliferator-activated receptor-gamma2 gene is associated with lower serum insulin levels in nonobese African Americans: the Atherosclerosis Risk in Communities Study. Diabetes 2003; 52(6): 1568-72.
27. Ghoussaini M, Meyre D, Lobbens S, Charpentier G, Clément K, Charles MA, et al. Implication of the Pro12Ala polymorphism of the PPAR-gamma 2 gene in type 2 diabetes and obesity in the French population. BMC Med Genet 2005; 6: 11.
28. Kaydashev IP, Rasin AM, Shlykova OA, Gorbas' IM, Smirnova IP, Petrushov AV, et al. Frequency of the Pro12Ala-polymorphism of the gene PPARγ2 in the Ukrainian population and its possible relation to the development of the metabolic syndrome. Cytol Genet 2007; 41(5): 298-302.
29. Pintérová D, Cerná M, Kolostová K, Novota P, Cimburová M, Romzová M, et al. The frequency of alleles of the Pro12Ala polymorphism in PPARgamma2 is different between healthy controls and patients with type 2 diabetes. Folia Biol (Praha) 2004; 50(5): 153-6.
30. Xita N, Lazaros L, Georgiou I, Tsatsoulis A. The Pro12Ala Polymorphism of the PPAR-gamma gene is not associated with the polycystic ovary syndrome. Hormones (Athens) 2009; 8(4): 267-72.
31. Fu M, Chen H, Li X, Li J, Wu B, Cheng L, et al. Association of Pro12Ala variant in peroxisome proliferatoractivated receptor-gamma2 gene with type 2 diabetes mellitus. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2002; 19(3): 234-8. (Chinese).
32. Li LL, Ma XL, Ran JX, Sun XF, Xu LM, Ren J, et al. Genetic polymorphism of peroxisome proliferatoractivated receptor-gamma 2 Pro12Ala on ethnic susceptibility to diabetes in Uygur, Kazak and Han subjects. Clin Exp Pharmacol Physiol 2008; 35(2): 187-91.
33. Hwang KR, Choi YM, Kim JM, Lee GH, Kim JJ, Chae SJ, et al. Association of peroxisome proliferatoractivated receptor-gamma 2 Pro12Ala polymorphism with advanced-stage endometriosis. Am J Reprod Immunol 2010; 64(5): 333-8.
34. Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J, et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 2000; 26(1): 76-80.
35. Douglas JA, Erdos MR, Watanabe RM, Braun A, Johnston CL, Oeth P, et al. The peroxisome poliferatoractivated receptor-γ2 Pro12Ala variant: association with type 2 diabetes and trait differences. Diabetes 2001; 50: 886-90.